E-prescribing mixes policy, politics to create better healthcare
Preventable medication errors are resulting in $3.5 billion in drug-injury related healthcare costs. To address this crisis, the IoM recommends that the entire system move to electronic prescribing (e-prescribing) by 2010.
One year ago, the Institute of Medicine (IoM) made national headlines when it estimated that 1.5 million preventable medication errors are occurring annually throughout our nation's health system and are resulting in $3.5 billion in drug-injury related healthcare costs. To address this crisis, the IoM recommended that the entire system move to electronic prescribing (e-prescribing) by 2010.
Leading policymakers from both sides, including then-Senate Finance Committee Chair Charles Grassley, rushed to announce support for the IoM's recommendations and reiterated the need for Congress to act. Senator Hillary Clinton immediately called for a national, uniform e-prescribing standard to replace a patchwork of conflicting and duplicative state laws. Indicative of the broad support that e-prescribing enjoys, AARP, AFL-CIO, Consumers Union, Pharmaceutical Care Management Association, and the U.S. Chamber of Commerce jointly signed a letter supporting the effort, noting that "widespread adoption of e-prescribing will save lives, improve quality, and reduce healthcare costs." Yet, for various reasons, Congress has not acted.
Despite real barriers to systemwide adoption, the marketplace is working hard to make e-prescribing a reality. A number of competing e-prescribing initiatives are under way at the behest of retail pharmacies, payors, and pharmacy benefit managers (PBMs), including SureScripts and RxHub. While having different business models and degrees of sophistication, they share a common goal: to use cutting-edge technology to provide patients, physicians, pharmacists, and payors with better data and to improve quality by reducing adverse drug interactions and providing real-time safety checks.
Private and public payors are racing to implement e-prescribing because the benefits are so apparent. E-prescribing can:
Despite the clear benefits, physicians have failed to embrace available e-prescribing technology. According to a new poll of 400 physicians conducted by Ayres McHenry & Associates, only one in 10 physicians uses e-prescribing technology on a regular basis. Almost two of three physicians report implementing e-prescribing is not a priority. In 2003, Congress attempted to require physicians participating in Medicare Part D to use e-prescribing technology, but the requirement was dropped in the face of fierce opposition by the American Medical Association primarily because of physicians' cost concerns.
As consumers, payors, and policymakers are demanding greater value for their health care dollars, e-prescribing is a logical place to start. E-prescribing will only happen with the support of physicians, who have thus far stalled progress. With a new Congress in place, now may be the time for a fresh start.
Phil Blando is a Partner with AB+M Partners, a health care consulting firm in Washington.
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
